•
The strategy is to continue to grow as a research-based biopharmaceuticalcompany focused on offering quality products to customers and potentialpartners. Key aspects of the strategy are to:
•
1. Increase revenues by offering innovative new products, growing existingproduct lines and continuing to offer exceptional customer service;
•
2. increase profitability by continuing to improve operational efficiency, workingcapital management and modernization of equipment;
•
3. enlarge and diversify customer base to reduce dependence on a limitednumber of significant customers;
•
4. develop and market the proprietary GelSite
®
polymer technology for deliveryof vaccines and therapeutics;
•
5. enter into strategic partnerships and collaboration arrangements related tothe GelSite
®
technology; and
•
6. continue to develop the knowledge of polymers and their relationship tovaccines and bioactive protein and peptide therapeutics.
Problemsof thestudyHas the Patterson operation been successful? To the degree that it can be judged a success, what factors have contributed to it?2. Identify the leadership styles of Fred Hammond and May Allison. Apply several of the leadership models to the case, such as Fiedler’s contingency model and the Hersey-Blenchard situational model.3. Comment on the informal organization at Patterson. In what ways did the employees create their own “company”? 4. Review Herzberg’s two
-
factor model. Why didn’t the change in physical working conditions (a deterioration of a hygiene factor) have a negativeeffect on productivity? What did cause the workers to be productive?
SolutionsFrom TheStudyQuestion-1: Has the Patterson operationbeen successful? To the degree that it canbe judged a success, what factors havecontributed to it?
From the study, we have learnt that due to lowproductivity, low employee morale and high unitcosts, the Section 10 was turned to ThePatterson Operation.
But though the